The New Treatment Initiative
The COVID-19 pandemic put mental health squarely at the top of our national agenda. In response, HDRF began a fast-track research program called the New Treatment Initiative. For 2021-2024, HDRF awarded sizeable grants to four universities in order to accelerate novel, promising treatments for depression to the clinical trial stage.
James W. Murrough, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Jennifer M. Coughlin, M.D.
Johns Hopkins
Jyoti Mishra, Ph.D.
University of California-San Diego, Director of NEATLabs
Heather Abercrombie, Ph.D.
University of Wisconsin-Madison
Simon Goldberg, Ph.D.
University of Wisconsin-Madison